Cardiovascular Safety During and After Use of Phentermine and Topiramate

CONTEXT: Increases in heart rate were seen during the clinical program for fixed-dose combination phentermine (PHEN) and topiramate (TPM), an oral medication indicated for weight management; however, the effect on cardiovascular (CV) outcomes is uncertain. OBJECTIVE: The aim of the present study was...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Endocrinol Metab
Glavni autori: Ritchey, Mary E, Harding, Abenah, Hunter, Shannon, Peterson, Craig, Sager, Philip T, Kowey, Peter R, Nguyen, Lan, Thomas, Steven, Cainzos-Achirica, Miguel, Rothman, Kenneth J, Andrews, Elizabeth B, Anthony, Mary S
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2018
Teme:
Clinical Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6318778/
https://ncbi.nlm.nih.gov/pubmed/30247575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-01010
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items